| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $93,229,412 ) (Continued on the next page) |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK137998 | An Integrated Lifestyle Intervention to Promote Cardiometabolic Health among Emerging Adult Women | 000 | 3 | NIH | 3/26/2026 | $310,500 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI167857 | Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis | 000 | 5 | NIH | 1/30/2026 | $571,945 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA290863 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC) | 002 | 2 | NIH | 4/16/2026 | $64,040 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA290863 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC) | 001 | 2 | NIH | 4/13/2026 | $0 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA290863 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC) | 000 | 2 | NIH | 4/2/2026 | $576,356 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01FD006071 | Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal) | 000 | 6 | FDA | 4/23/2026 | $391,286 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AA020912 | 4/11 Neuroimmune and extracellular matrix interactions in alcohol consumption | 000 | 16 | NIH | 2/6/2026 | $426,938 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK135815 | Modeling genetic contributions to biliary atresia | 000 | 4 | NIH | 5/4/2026 | $588,673 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA060210 | The role of norepinephrine transporter phosphorylation in amphetamine reward | 000 | 3 | NIH | 7/21/2026 | $565,271 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA030005 | Genetic, Social, and Developmental Epidemiology of Drug Use Disorders | 000 | 15 | NIH | 6/1/2026 | $1 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AG076481 | Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease | 001 | 5 | NIH | 6/5/2026 | $1,513,190 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30AR081102 | Extracellular Matrix Vesicles and Intercellular Communication of Osteoblast-lineage Cells | 000 | 4 | NIH | 6/8/2026 | $46,714 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM155045 | Dissecting mechanisms of collective migration | 000 | 3 | NIH | 6/5/2026 | $366,579 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01NS124974 | Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1) | 000 | 4 | NIH | 7/7/2026 | $955,206 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE035939 | Mapping and Modulating Endothelial Dysfunction in Peri-implantitis | 000 | 1 | NIH | 7/9/2026 | $446,611 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG076912 | Probing neuroinflammation in Alzheimer's disease with NLRP3 PET radiotracers | 000 | 2 | NIH | 3/24/2026 | $625,387 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61HL178692 | Targeted Interleukin-1 Blockade in Acute Systolic Heart Failure | 000 | 1 | NIH | 8/13/2026 | $752,390 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23NS144702 | Clinical Outcome Assessments in Congenital Myotonic Dystrophy | 000 | 1 | NIH | 8/7/2026 | $173,335 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK149540 | Renal medullary telocyte in pressure natriuresis and arterial blood pressure control: Piezo1 channel as a pressure sensor | 000 | 1 | NIH | 8/13/2026 | $714,743 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31DA067079 | Respiratory, Neuroinflammatory, and Motor-impairing Effects of Acute and Chronic Fentanyl and Xylazine Exposure in Mice | 000 | 1 | NIH | 7/16/2026 | $45,530 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03DE036434 | HNSCC and Iron addiction | 000 | 1 | NIH | 8/6/2026 | $310,500 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31DA067103 | Emerging Synthetic Opioids and α2-agonists: Translational Investigation of Respiratory and Behavioral Risk | 001 | 1 | NIH | 7/16/2026 | $0 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31DA067103 | Emerging Synthetic Opioids and α2-agonists: Translational Investigation of Respiratory and Behavioral Risk | 000 | 1 | NIH | 7/16/2026 | $43,686 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA065318 | Assessing the Abuse Liability of 6-Methyl Nicotine | 000 | 1 | NIH | 8/19/2026 | $657,471 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R50CA318775 | Driving Transformation in NCI-sponsored Clinical Trials through Education, Leadership, and Community Partnership: An NCI-R50 Clinical-Scientist Award | 000 | 1 | NIH | 8/11/2026 | $129,194 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21ES038630 | Understanding the role of lipid transport proteins in PFAS exposure | 000 | 1 | NIH | 6/23/2026 | $426,938 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R56DE034980 | Dyrk1a, a Goldilocks protein in embryonic development | 000 | 1 | NIH | 8/10/2026 | $1 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R56DE034980 | Dyrk1a, a Goldilocks protein in embryonic development | 000 | 1 | NIH | 8/10/2026 | $378,519 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32TR006000 | CTSA Postdoctoral T32 at Virginia Commonwealth University | 000 | 1 | NIH | 8/11/2026 | $91,070 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA064914 | Non-nicotine compounds that contribute to abuse liability of electronic nicotine delivery systems | 001 | 1 | NIH | 7/22/2026 | $0 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA064914 | Non-nicotine compounds that contribute to abuse liability of electronic nicotine delivery systems | 000 | 1 | NIH | 7/6/2026 | $591,405 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DA062929 | Does Astrocyte Elevated Gene-1 (AEG-1), a Novel Transcriptional Regulator, Mediate an Anti-opioid System? | 000 | 1 | NIH | 6/8/2026 | $426,938 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K99AI199056 | Orientia tsutsugamsuhi promotes interplay between circadian rhythm and hypoxic responses | 000 | 1 | NIH | 5/11/2026 | $138,861 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23NS144704 | Identifying Genetic Modifiers of Disease Severity in Myotonic Dystrophy Type 1 | 000 | 1 | NIH | 7/7/2026 | $194,907 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3EY036558 | Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury | 001 | 2 | NIH | 6/18/2026 | $8,864 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM160681 | C18-Ceramide as an essential factor in iron dependent cell death | 000 | 2 | NIH | 8/18/2026 | $437,446 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R00AA030611 | Dissecting the co-occurrence of alcohol use/problems and suicidal behaviors: the roles of genetic liability and neurocognitive mechanisms | 001 | 4 | NIH | 8/3/2026 | $241,966 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K12CA300624 | The Massey/VCU’s McCaskill-Stevens K12 for Community Oncology and Prevention Research | 000 | 1 | NIH | 4/24/2026 | $54,000 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23DK141991 | Advancing sacral neuromodulation with objective analytics and prediction | 000 | 2 | NIH | 7/28/2026 | $170,667 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG3EY036558 | Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury | 001 | 2 | NIH | 6/18/2026 | $534,090 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K08DK140618 | The transcription factor RUNX1 is pivotal in TGFβ-activated cholangiocyte signaling with the immune system in biliary fibrosis | 000 | 2 | NIH | 7/29/2026 | $176,148 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA308922 | Utilizing Glycosaminoglycans as a Theragnostic Approach for Treating Platinum-Resistant Gynecological Malignancies | 000 | 1 | NIH | 5/11/2026 | $399,187 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30AA033246 | The circRNA-Sphingolipid Axis: A Novel Driver of Alcohol-Associated Liver Disease. | 001 | 1 | NIH | 6/30/2026 | $0 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30AA033246 | The circRNA-Sphingolipid Axis: A Novel Driver of Alcohol-Associated Liver Disease. | 000 | 1 | NIH | 6/30/2026 | $45,406 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG093992 | Selective Vulnerability of Cholinergic Neurons in Alzheimer’s Disease | 000 | 1 | NIH | 12/26/2025 | $552,883 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA296691 | Explore a novel therapeutic approach in advanced prostate cancer | 000 | 1 | NIH | 5/7/2026 | $399,187 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA308828 | Potentiating efficacy of TROP2 targeted antibody-drug conjugates | 000 | 1 | NIH | 6/30/2026 | $511,930 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA058089 | Reprogramming KZFP function to understand drug-specific transcription and behavior | 000 | 3 | NIH | 2/10/2026 | $502,202 |
| | 2026 | 2026 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HD112416 | A Hospital-based Intervention for Youth Injured through Violence | 000 | 2 | NIH | 8/20/2026 | $1,854,381 |
|
